AU5634400A - Shank proteins and methods of use thereof - Google Patents
Shank proteins and methods of use thereofInfo
- Publication number
- AU5634400A AU5634400A AU56344/00A AU5634400A AU5634400A AU 5634400 A AU5634400 A AU 5634400A AU 56344/00 A AU56344/00 A AU 56344/00A AU 5634400 A AU5634400 A AU 5634400A AU 5634400 A AU5634400 A AU 5634400A
- Authority
- AU
- Australia
- Prior art keywords
- methods
- shank proteins
- shank
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14071599P | 1999-06-24 | 1999-06-24 | |
US60140715 | 1999-06-24 | ||
PCT/US2000/017322 WO2000078921A2 (en) | 1999-06-24 | 2000-06-23 | Shank proteins and methods of use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5634400A true AU5634400A (en) | 2001-01-09 |
Family
ID=22492491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU56344/00A Abandoned AU5634400A (en) | 1999-06-24 | 2000-06-23 | Shank proteins and methods of use thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5634400A (en) |
WO (1) | WO2000078921A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
GB0119555D0 (en) * | 2001-08-10 | 2001-10-03 | Novartis Forschungsstiftung | Markers and screens |
EP1831403A4 (en) | 2004-12-30 | 2010-04-28 | Univ Louisville Res Found | Genetic markers of schizophrenia |
EP2297325A4 (en) * | 2008-05-29 | 2011-10-05 | Chum | Methods of stratifying, prognosing and diagnosing schizophrenia, mutant nucleic acid molecules and polypeptides |
-
2000
- 2000-06-23 AU AU56344/00A patent/AU5634400A/en not_active Abandoned
- 2000-06-23 WO PCT/US2000/017322 patent/WO2000078921A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2000078921A2 (en) | 2000-12-28 |
WO2000078921A3 (en) | 2001-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
AU2001277172A1 (en) | Bstp-trans protein and related reagents and methods of use thereof | |
AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
AU2001267475A1 (en) | Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU2002314466A1 (en) | Withasol and methods of use | |
AU6340600A (en) | Telomerase inhibitors and methods of their use | |
HK1053673A1 (en) | Methods of protein destabilization and uses thereof | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU2002246808A1 (en) | Human nucleic acids and polypeptides and methods of use thereof | |
AU3622600A (en) | Metalloproteinases and methods of use therefor | |
AU2001278011A1 (en) | Bstp-ecg1 protein and related reagents and methods of use thereof | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU6585498A (en) | Novel uncoupling protein and methods of use | |
AU2002365202A1 (en) | Synthetic genes for malarial proteins and methods of use | |
AU2001277202A1 (en) | Bstp-ras/rerg protein and related reagents and methods of use thereof | |
AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
AU2001261375A1 (en) | Human caspase-12 materials and methods | |
AU3501700A (en) | Human endokine alpha and methods of use | |
AU5634400A (en) | Shank proteins and methods of use thereof | |
AU2001249692A1 (en) | Phospholipid scramblases and methods of use thereof | |
AU2136401A (en) | P450rai-2 and related proteins | |
AU1103701A (en) | Glutamate transporter associated proteins and methods of use thereof | |
AU3725500A (en) | Hand-held bidet and method of use | |
AU2001284651A1 (en) | Secreted proteins and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |